Recent advances in clinical practice and in basic research on diabetic neuropathy

Brain and Nerve

Volumn 63, Issue 6, 2011, Pages 571-582

  Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Clinical staging; Diabetic neuropathy; Pathogenesis; Small fiber damage; Treatment

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE C; TRANSCRIPTION FACTOR;

ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; CORNEA; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE DURATION; GLUCOSE BLOOD LEVEL; GLYCATION; HUMAN; HYPERTENSION; INNERVATION; LASER MICROSCOPY; MEDICAL RESEARCH; NERVE BIOPSY; NERVE CONDUCTION; PATHOGENESIS; PERIPHERAL NERVE INJURY; PHENOTYPE; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; RISK FACTOR; SIGNAL TRANSDUCTION; SKIN BIOPSY; SOCIOECONOMICS; THERAPY EFFECT;

ANIMALS; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; HUMANS;

EID: 79959391246     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Martin CL, Albers J, Herman WH, Cleary P, Waberski B, et al: Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 29: 340-344, 2006 (Pubitemid 44106515)
2. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117, 1995
3. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 352: 837-853, 1998
4. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, et al: Vascular risk factors and diabetic neuropathy. N Engl J Med 352: 341-350, 2005
5. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, et al: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17: 1281-1289, 1994 (Pubitemid 24324972)
6. Bril V, Perkins BA: Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25: 2048-2052, 2002 (Pubitemid 41071067)
7. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, et al: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33: 2285-2293, 2010
8. Peripheral Nerve 21: 372-373, 2010
9. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ: Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108: 861-880, 1985 (Pubitemid 16185406)
10. Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, et al: The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 42: 1164-1170, 1992
11. Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, et al: Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care 30: 2619-2625, 2007 (Pubitemid 47547807)
12. Papanas N, Ziegler D: New diagnostic tool for diabetic distal symmetric polyneuropathy. J Diabetes Compl 25: 44-51, 2011
13. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, et al: The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127: 1606-1615, 2004 (Pubitemid 38899413)
14. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M: The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60: 108-111, 2003
15. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, et al: Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29: 1294-1299, 2006 (Pubitemid 44125925)
16. Malik RA, Kallinikos P, Abbott CA, van Schie CH, Morgan P, et al: Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 46: 683-688, 2003 (Pubitemid 36808188)
17. Mehra S, Tavakoli M, Kallinikos PA, Efron N, Boulton AJ, et al: Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 30: 2608-2612, 2007 (Pubitemid 47547805)
18. Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, et al: High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. Diabetes 56: 2598-2608, 2007
19. Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA: Complications: neuropathy, pathogenetic considerations. Diabetes Care 15: 1902-1925, 1992
20. Yagihashi S, Yamagishi SI, Wada R, Baba M, Hohman TC, et al: Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 124: 2448-2458, 2001 (Pubitemid 33134934)
21. 2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 55: 1946-1953, 2006
22. Hwang YC, Shaw S, Kaneko M, Redd H, Marrero MB, et al: Aldose reductase pathway mediates JAKSTAT signaling: a novel axis in myocardial ischemic injury. FASEB J 19: 795-797, 2005
23. Yagihashi S, Mizukami H, Ogasawara S, Yamagishi S, Nukada H, et al: The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice. J Pathol 220: 530-541, 2010
24. Baba M, Nukada H, McMorran D, Takahashi K, Wada R, et al: Prolonged ischemic conduction failure after reperfusion in diabetic nerve. Muscle Nerve 33: 350-355, 2006
25. Sugimoto K, Yasujima M, Yagihashi S: Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 14: 953-961, 2008 (Pubitemid 351753282)
26. Wada R, Yagihashi S: Role of advanced glycation end products and their receptors in development of diabetic neuropathy. Ann N Y Acad Sci 1043: 598-604, 2005 (Pubitemid 41123949)
27. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, et al: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114: 1741-1751, 2004 (Pubitemid 40385530)
28. Nishizawa Y, Wada R, Baba M, Hanyu-Itabashi C, Takeuchi M, et al: Neuropathy induced by exogenously administered advanced glycation end-products. J Diabetes Invest 1: 40-49, 2010
29. Haupt E, Ledermann H, Köpeke W: Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 43: 71-77, 2005 (Pubitemid 40298057)
30. Cameron NE, Cotter MA, Maxfield EK: Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36: 299-304, 1993 (Pubitemid 23106012)
31. Huang TJ, Price SA, Chilton L, Calcutt NA, Tomlinson DR, et al: Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52: 2129-2136, 2003 (Pubitemid 36919808)
32. Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL: Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol 2: 620-628, 2006 (Pubitemid 44614088)
33. Obrosova IG, Li F, Abatan OI, Forsell MA, Komjáti K, et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 53: 711-720, 2004 (Pubitemid 38270641)
34. Towns R, Pietropaolo M, Wiley JW: Stimulation of autophagy by autoantibody-mediated activation of death receptor cascades. Autophagy 4: 715-716, 2008
35. Younger DS, Rosoklija G, Hays AP, Trojaborg W, Latov N: Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve 19: 722-727, 1996 (Pubitemid 26134582)
36. Pop-Busui R, Marinescu V, Van Huysen C, Li F, Sullivan K, et al: Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. Diabetes 51: 2619-2628, 2002. (Pubitemid 34827415)
37. Yamagishi S, Ogasawara S, Mizukami H, Yajima N, Wada R, et al. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats. J Neurochem 104: 491-499, 2008 (Pubitemid 350293884)
38. Kato N, Nemoto K, Nakanishi K, Morishita R, Kaneda Y, et al: Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats. Diabetes 54:846-854, 2005
39. Pawson EJ, Duran-Jimenez B, Surosky R, Brooke HE, Spratt SK, et al: Engineered zinc finger protein-mediated VEGF-a activation restores deficient VEGF-a in sensory neurons in experimental diabetes. Diabetes 59: 509-518, 2010
40. Naruse K, Hamada Y, Nakashima E, Kato K, Mizubayashi R, et al: Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 54: 1823-1828, 2005
41. Jeong JO, Kim MO, Kim H, Lee MY, Kim SW, et al: Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 119: 699-708, 2009
42. Yagihashi S, Mizukami H, Yamagishi SI, Ogasawara S, Sugimoto K, et al: Increased nerve fiber regeneration and neurotrophic support in long-term diabetic STZ-rats transplanted with adipose-tissue-derived mesenchymal stem cells. J Periph Nerve Syst 14(Suppl): 159, 2009
43. Terashima T, Kojima H, Fujimiya M, Matsumura K, Oi J, et al: The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy. Proc Natl Acad Sci USA 102: 12525-12530, 2005 (Pubitemid 41266392)
44. Busik JV, Tikhonenko M, Bhatwadekar A, Opreanu M, Yakubova N, et al: Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med 206: 2897-2906, 2009
45. Tesfaye S, Tandan R, Bastyr EJ 3rd, Kles KA, Skljarevski V,et al: Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials. Diabetes Care 30: 2626-2632, 2007 (Pubitemid 47547808)
46. Satoh J, Yagihashi S, Baba M, Suzuki M, Arakawa A, et al: Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabet Med 28: 109-116, 2011